CryoTherapeutics
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.
Last updated on
About CryoTherapeutics
Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$13MCategory
Industry
Medical DevicesLocation
City
KoelnState
North Rhine-WestphaliaCountry
GermanyCryoTherapeutics
Find your buyer within CryoTherapeutics